Related Experiment Videos
Empiric therapy for pneumonia in the surgical intensive care unit
1Department of Surgery, University of Tennessee, Memphis, Tennessee, USA.
Abstract:
Empiri c therapy of ventilator-associated pneumonia (VAP) in surgical patients should be based on intensive care unit (ICU)-specific surveillance data, because microbial flora patterns vary widely between geographic regions as well as within hospitals. Surgical ICUs have higher VAP rates than other units. Data from the National Nosocomial Infection Surveillance (NNIS) System report Pseudomonas aeruginosa and Staphylococcus aureus to be the most frequent isolates (each 17.4%). Data from the NNIS documents high resistance patterns in ICUs compared with hospitals at large, as well as unit-specific patterns. VAP risk factors for surgical patients include thoracoabdominal surgery, altered level of consciousness, advanced age, diabetes mellitus, malnutrition, chronic obstructive pulmonary disease, and prior antibiotic administration. Promising prevention strategies include restricting ventilator circuit changes, in-line heat moisture exchange filters, semi-recumbant positioning, and continuous subglottic aspiration. Pharmacodynamics should be considered when choosing antibiotic regimens. Postantibiotic effect and time-dependent versus concentration-dependent killing should be studied in clinical trials. Current guidelines for choosing regimens have been well developed by the American Thoracic Society.
Insights
Empirical therapy for ventilator-associated pneumonia (VAP) in surgical patients requires ICU-specific data due to varying microbial patterns. Tailoring treatment to local surveillance data improves VAP management and outcomes.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Surgical Infections
Background:
- Ventilator-associated pneumonia (VAP) presents unique challenges in surgical intensive care units (ICUs), often exhibiting higher incidence rates compared to other hospital units.
- Microbial flora patterns and antibiotic resistance vary significantly across different geographic regions and healthcare facilities, necessitating localized surveillance data for effective treatment.
- Surgical patients face specific risk factors for VAP, including thoracoabdominal surgery, compromised consciousness, advanced age, comorbidities like diabetes mellitus and COPD, and prior antibiotic exposure.
Purpose of the Study:
- To emphasize the critical need for ICU-specific surveillance data in guiding empirical therapy for ventilator-associated pneumonia (VAP) in surgical patients.
- To highlight the importance of understanding regional and hospital-specific microbial patterns and resistance profiles for optimizing VAP treatment strategies.
- To review established risk factors and emerging prevention strategies for VAP in the surgical population.
Main Methods:
- Analysis of data from the National Nosocomial Infection Surveillance (NNIS) System to identify prevalent pathogens and resistance patterns in ICUs.
- Review of established and potential risk factors associated with VAP development in surgical patients.
- Evaluation of current and proposed VAP prevention strategies, including ventilator circuit management and patient positioning.
Main Results:
- Pseudomonas aeruginosa and Staphylococcus aureus are identified as the most frequent isolates in VAP cases, each accounting for 17.4% of infections according to NNIS data.
- ICUs demonstrate higher rates of antibiotic resistance compared to general hospital settings, with distinct unit-specific patterns observed.
- Key risk factors for VAP in surgical patients include thoracoabdominal surgery, altered consciousness, advanced age, diabetes, malnutrition, COPD, and prior antibiotic use.
Conclusions:
- Empirical VAP therapy in surgical ICUs must be informed by local surveillance data to address prevalent pathogens and resistance.
- Promising prevention strategies include optimizing ventilator management, utilizing semi-recumbent positioning, and considering continuous subglottic aspiration.
- Pharmacodynamic principles, including post-antibiotic effects and concentration-dependent killing, should guide antibiotic regimen selection, aligning with established guidelines like those from the American Thoracic Society.